Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.32
-1.4%
$1.34
$0.90
$2.95
$67.01M-0.9830,229 shs7,757 shs
Biodesix, Inc. stock logo
BDSX
Biodesix
$0.38
-9.2%
$0.40
$0.17
$1.85
$60.56M15.81 million shs3.52 million shs
Marpai, Inc. stock logo
MRAI
Marpai
$1.23
+2.5%
$1.35
$0.43
$1.68
$21.24M4.6616,818 shs18,450 shs
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
$8.60
-0.8%
$7.30
$5.80
$26.99
$62.34M0.827,174 shs1,771 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
+0.68%+1.44%-2.26%-19.82%-7.01%
Biodesix, Inc. stock logo
BDSX
Biodesix
-20.82%-6.84%+0.49%+44.05%-76.93%
Marpai, Inc. stock logo
MRAI
Marpai
-2.44%-11.11%-19.46%-13.67%+112.39%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-1.34%-0.87%+30.08%+33.93%-68.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.32
-1.4%
$1.34
$0.90
$2.95
$67.01M-0.9830,229 shs7,757 shs
Biodesix, Inc. stock logo
BDSX
Biodesix
$0.38
-9.2%
$0.40
$0.17
$1.85
$60.56M15.81 million shs3.52 million shs
Marpai, Inc. stock logo
MRAI
Marpai
$1.23
+2.5%
$1.35
$0.43
$1.68
$21.24M4.6616,818 shs18,450 shs
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
$8.60
-0.8%
$7.30
$5.80
$26.99
$62.34M0.827,174 shs1,771 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
+0.68%+1.44%-2.26%-19.82%-7.01%
Biodesix, Inc. stock logo
BDSX
Biodesix
-20.82%-6.84%+0.49%+44.05%-76.93%
Marpai, Inc. stock logo
MRAI
Marpai
-2.44%-11.11%-19.46%-13.67%+112.39%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-1.34%-0.87%+30.08%+33.93%-68.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
Biodesix, Inc. stock logo
BDSX
Biodesix
2.80
Moderate Buy$1.75366.54% Upside
Marpai, Inc. stock logo
MRAI
Marpai
0.00
N/AN/AN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
2.50
Moderate Buy$16.2588.95% Upside

Current Analyst Ratings Breakdown

Latest MRAI, ATPC, BDSX, and PIII Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/28/2025
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$20.00
(Data available from 9/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.32M50.05N/AN/A$0.48 per share2.75
Biodesix, Inc. stock logo
BDSX
Biodesix
$71.32M0.77N/AN/A$0.14 per share2.68
Marpai, Inc. stock logo
MRAI
Marpai
$34.87M0.61N/AN/A($1.72) per share-0.72
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
$1.50B0.04N/AN/A$10.58 per share0.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.47M-$0.41N/AN/A-183.13%-20.32%-18.55%11/12/2025 (Estimated)
Biodesix, Inc. stock logo
BDSX
Biodesix
-$42.93M-$0.29N/AN/AN/A-53.66%-269.67%-43.94%11/7/2025 (Estimated)
Marpai, Inc. stock logo
MRAI
Marpai
-$28.75M-$0.87N/AN/A-85.70%N/A-100.23%11/11/2025 (Estimated)
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-$135.85M-$46.01N/AN/AN/A-9.99%-183.60%-17.83%11/11/2025 (Estimated)

Latest MRAI, ATPC, BDSX, and PIII Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-$3.29-$6.23-$2.94-$6.23$356.52 million$355.79 million
8/13/2025Q2 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.01N/A-$0.01N/AN/A
8/7/2025Q2 2025
Biodesix, Inc. stock logo
BDSX
Biodesix
-$0.07-$0.08-$0.01-$0.08$18.47 million$20.02 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
Biodesix, Inc. stock logo
BDSX
Biodesix
N/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
20.36
20.33
Biodesix, Inc. stock logo
BDSX
Biodesix
41.11
2.14
2.14
Marpai, Inc. stock logo
MRAI
Marpai
N/A
0.82
0.82
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
2.29
0.31
0.31

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
Biodesix, Inc. stock logo
BDSX
Biodesix
20.96%
Marpai, Inc. stock logo
MRAI
Marpai
49.75%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
7.75%

Insider Ownership

CompanyInsider Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
9.67%
Biodesix, Inc. stock logo
BDSX
Biodesix
30.10%
Marpai, Inc. stock logo
MRAI
Marpai
46.10%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
17.79%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
4050.01 million45.17 millionNot Optionable
Biodesix, Inc. stock logo
BDSX
Biodesix
220146.63 million102.50 millionOptionable
Marpai, Inc. stock logo
MRAI
Marpai
15017.27 million5.61 millionNo Data
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
5007.19 million5.91 millionNot Optionable

Recent News About These Companies

Reviewing P3 Health Partners (NASDAQ:PIII) and Biotricity (OTCMKTS:BTCY)
P3 Health Partners Earnings Call: Challenges and Progress
P3 Health Partners Announces Second Quarter 2025 Results
P3 Health Partners Inc. (PIII) - Yahoo Finance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$1.32 -0.02 (-1.42%)
Closing price 03:53 PM Eastern
Extended Trading
$1.33 +0.01 (+0.68%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Biodesix stock logo

Biodesix NASDAQ:BDSX

$0.38 -0.04 (-9.18%)
Closing price 04:00 PM Eastern
Extended Trading
$0.37 -0.01 (-1.89%)
As of 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Marpai stock logo

Marpai NASDAQ:MRAI

$1.23 +0.03 (+2.50%)
As of 03:34 PM Eastern

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

P3 Health Partners stock logo

P3 Health Partners NASDAQ:PIII

$8.60 -0.07 (-0.81%)
Closing price 03:59 PM Eastern
Extended Trading
$8.56 -0.04 (-0.41%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.